These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7068672)
1. Conformational comparisons of oxytocin agonists, partial agonists, and antagonists using laser Raman and circular dichroism spectroscopy. Examination of 1-penicillamine and diastereoisomeric analogues. Hruby VJ; Mosberg HI; Fox JW; Tu AT J Biol Chem; 1982 May; 257(9):4916-24. PubMed ID: 7068672 [TBL] [Abstract][Full Text] [Related]
2. Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution. Mosberg HI; Hruby VJ; Meraldi JP Biochemistry; 1981 May; 20(10):2822-8. PubMed ID: 7248250 [TBL] [Abstract][Full Text] [Related]
3. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling. Bélec L; Blankenship JW; Lubell WD J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022 [TBL] [Abstract][Full Text] [Related]
4. Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and bioassay. Fric I; Hlavacek J; Rockway TW; Chan WY; Hruby VJ J Protein Chem; 1990 Feb; 9(1):9-15. PubMed ID: 2340080 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonists. Hruby VJ; Mosberg HI; Hadley ME; Chan WY; Powell AM Int J Pept Protein Res; 1980 Nov; 16(5):372-81. PubMed ID: 7216613 [TBL] [Abstract][Full Text] [Related]
6. Conformational studies of oxytocin analogues with different ring sizes. I. Circular dichroism. Kawano K; Kobayashi Y; Kyogoku Y; Morikawa T; Sakakibara S Biochim Biophys Acta; 1979 May; 578(1):87-95. PubMed ID: 36924 [TBL] [Abstract][Full Text] [Related]
7. Conformational studies of peptide hormones using laser Raman and circular dichroism spectroscopy. A comparative study of oxytocin agonists and antagonists. Hruby VJ; Deb KK; Fox J; Bjarnason J; Tu AT J Biol Chem; 1978 Sep; 253(17):6060-7. PubMed ID: 681339 [No Abstract] [Full Text] [Related]
8. Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism. Meraldi JP; Hruby VJ; Brewster AI Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1373-7. PubMed ID: 266179 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological, conformational and dynamic properties of cycloleucine-2 analogues of oxytocin and [1-penicillamine]oxytocin. Hruby VJ; Rockway TW; Viswanatha V; Chan WY Int J Pept Protein Res; 1983 Jan; 21(1):24-34. PubMed ID: 6826279 [TBL] [Abstract][Full Text] [Related]
10. Laser Raman spectroscopy and circular dichroism studies of the peptide hormones mesotocin, vasotocin, lysine vasopressin, and arginine vasopressin. Conformational analysis. Tu AT; Lee J; Deb KK; Hruby VJ J Biol Chem; 1979 May; 254(9):3272-8. PubMed ID: 429348 [No Abstract] [Full Text] [Related]
11. The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs. Bélec L; Maletinska L; Slaninová J; Lubell WD J Pept Res; 2001 Sep; 58(3):263-73. PubMed ID: 11576333 [TBL] [Abstract][Full Text] [Related]
12. A Raman spectroscopic investigation of the disulfide conformation in oxytocin and lysine vasopressin. Maxfield FR; Scheraga HA Biochemistry; 1977 Oct; 16(20):4443-9. PubMed ID: 911768 [TBL] [Abstract][Full Text] [Related]
13. Circular-dichroic spectra of vasopressin analogues and their cyclic fragments. Fric I; Kodícek M; Flegel M; Zaoral M Eur J Biochem; 1975 Aug; 56(2):493-502. PubMed ID: 240713 [TBL] [Abstract][Full Text] [Related]
14. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation. Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387 [TBL] [Abstract][Full Text] [Related]
15. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8. Flouret G; Chaloin O; Slaninová J J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity studies of a novel bicyclic oxytocin antagonist. Smith DD; Slaninova J; Hruby VJ J Med Chem; 1992 May; 35(9):1558-63. PubMed ID: 1578481 [TBL] [Abstract][Full Text] [Related]
17. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor. Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185 [TBL] [Abstract][Full Text] [Related]
18. Conformational features of bradykinin. A circular dichroism study of the aromatic side-chains. Lintner K; Fermandjian S; Regoli D; Barabé J Eur J Biochem; 1977 Dec; 81(2):395-401. PubMed ID: 598373 [TBL] [Abstract][Full Text] [Related]
19. Molecular biology of copper. A circular dichroism study on copper complexes of thionein and penicillamine. Rupp H; Voelter W; Weser U Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):755-65. PubMed ID: 241690 [TBL] [Abstract][Full Text] [Related]